Skip to content

Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

Randomized Clinical Trial of Robot-Assisted Intelligent Rehabilitation Treatment in Comparison With Standard Treatment for Methamphetamine Use Disorders and Alcohol Use Disorders

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04531384
Enrollment
200
Registered
2020-08-28
Start date
2020-12-01
Completion date
2022-12-31
Last updated
2022-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amphetamine Addiction

Brief summary

The purpose of this research is to evaluate the efficacy and safety of Robot-assisted rehabilitation intelligent system as a virtual stand-alone treatment, delivered with minimal clinical monitoring compared with treatment as usual in methamphetamine (MA) use disorders.

Detailed description

Based on artificial intelligence technology, face recognition technology, virtual reality technology to develop an available Robot-assisted rehabilitation intelligent system. Then, using this intelligent system as a new way of Psychotherapy to provide treatment for methamphetamine patients, and compare it with traditional treatment to verify the efficacy and safety of Robot-assisted rehabilitation intelligent system in Chinese methamphetamine patients.

Interventions

robot-assisted rehabilitation psychotherapy

OTHERstandard psychotherapy treatment

standard treatment at the compulsory isolated detoxification centers and non-compulsory isolated detoxification institutions

Sponsors

Shanghai Mental Health Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders; * Education level equal or more than 9 years; * Have normal or corrected-to-normal vision; * Have normal or corrected-to-normal hearing; * Less than 3 months before last drug use;

Exclusion criteria

* Current substance use (except nicotine or caffeine); * History of disease which influence cognition,such as seizure disorder、cerebrovascular disease、head injury or other severe medication conditions; * Intelligence quotient less than 70.

Design outcomes

Primary

MeasureTime frameDescription
Changes of galvanic skin response during the virtual reality based addiction assessment systemin 1 yearThe galvanic skin response is an emotional physiological indicator, and its unit is ohm.

Secondary

MeasureTime frameDescription
Anxietyin 1 yearAnxiety is assessed by the State-Trait Anxiety Scale (SAS). The score of the SAS scale is between 0 and 80. The higher the score, the more severe the anxiety symptoms.
Depressionin 1 yearDepression is assessed by the the Beck Depression Scale (SDS). The score of the SDS scale is between 0 and 80. The higher the score, the more severe the depression symptoms.
Attentional bias related to drugs and emotional stimulationin 1 yearThe emotional Stroop tests is used for assessed attentional bias. The indicator is the accuracy rate of the key presses, from 0 to 100%.
Treatment motivationin 1 yearUsing the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) to measure the treatment motivation of the participants. The score of the scale is between 19 and 95. The higher the score, the higher the treatment motivation.
Reaction inhibition abilityin 1 yearStop signal task is used for assess the reaction inhibition ability. The indicator is the reaction time when the participant completes the task, and its unit is milliseconds.
Changes of electroencephalogram power spectrum during the virtual reality based addictionin 1 yearThe electroencephalogram power spectrum reflects the functional status of the brain, and its unit is uV\^2.
Risky decision-makingin 1 yearBalloon Analogue Risk Task is used for assess the risky decision-making ability. The indicator is the average number of balloon blows, and its unit is times.

Countries

China

Contacts

Primary ContactMin Zhao
drminzhao@gmail.com64387250

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026